Stanford University
Showing 11-20 of 160 Results
-
Pamela A. Basto
Instructor, Medicine - Oncology
BioDr. Basto is a physician scientist and medical oncologist specializing in the diagnosis and treatment of gastrointestinal malignancies.
She attended The University of Texas graduating magna cum laude in biomedical engineering, subsequently gaining her Ph.D. in Medical Engineering and Medical Physics at the Harvard-MIT Health Science and Technology program the under the tutelage of Professors Robert Langer and Ulrich von Andrian at the Koch Institute for Integrative Cancer Research. Her thesis focused on developing next generation polymeric nanoparticle vaccines towards improved antigen specific cellular and humoral responses, work that has been translated into clinical trials. She completed medical school at Stanford University, followed by residency in internal medicine at The Mount Sinai Hospital in the ABIM research pathway, where she served on the ICU frontlines during the COVID-alpha wave at Elmhurst Hospital. She subsequently completed her hematology/oncology fellowship at Stanford University training in Professor Edgar Engleman’s lab in tumor immunology. Her translational research studies how cancers metastasize leveraging the immune system and designing therapeutics to interrupt this cascade. She was clinically trained by Professor Lipika Goyal in clinical and trial management of patients with hepatopancreatobiliary cancers.
As a clinician, she aims to create a welcoming partnership with patients during a difficult diagnosis based in trust and science, supported by an excellent clinical team. She welcomes patients from all backgrounds and aims to honor their values in culture, religion, and gender preferences. Her approach is to offer evidence based knowledge and the latest available treatments, including clinical trials, personalized to each individual’s tumor biology and their values. -
Allison Betof, MD, PhD, FASCO
Associate Professor of Medicine (Oncology)
BioDr. Allison Betof is an Associate Professor of Medicine (Oncology), Director of the Melanoma Program, Director of Solid Tumor Cellular Therapy, and Mark & Mary Stevens Endowed Scholar in Melanoma at Stanford University School of Medicine. Dr. Betof completed her MD and PhD at Duke University, Internal Medicine residency at Massachusetts General Hospital (Harvard University) and Medical Oncology Fellowship at Memorial Sloan Kettering Cancer Center. Dr. Betof’s laboratory focuses on understanding resistance to immune checkpoint blockade and cellular therapies for melanoma and other solid tumors. She is the Principal Investigator of clinical trials exploring novel treatments for immunotherapy-refractory melanoma and is internationally recognized for her expertise in brain/CNS metastasis and the use of novel cellular therapies. Dr. Betof has been a pioneer in the use of commercial tumor infiltrating lymphocyte (TIL) therapy for the treatment of melanoma and other solid tumors. She has received funding and awards for her clinical and translational investigative work from multiple high-profile organizations, including the American Society of Clinical Oncology (ASCO), National Institutes of Health (NIH), Melanoma Research Alliance, and Melanoma Research Foundation.
-
Douglas W. Blayney
Professor of Medicine (Oncology), Emeritus
Current Research and Scholarly InterestsImproving the quality of cancer care at Stanford, in our network of care, and nationally
-
Nam Quoc Bui
Clinical Associate Professor, Medicine - Oncology
BioDr. Bui is a Clinical Associate Professor of Medicine at the Stanford Cancer Institute and a specialist in Sarcoma. Dr. Bui earned an undergraduate degree in Computer Science at Stanford University and went on to earn his medical degree from the University of Texas Southwestern Medical Center. He completed Internal Medicine residency at Stanford Hospital and Hematology/Oncology fellowship at the University of California San Diego, where he performed extensive research in bioinformatics to analyze tumor sequencing data.
He is involved in numerous sarcoma clinical trials, leading efforts to take new therapeutics from the lab to clinical practice. His research background and interests are in the field of bioinformatics as applied to large data sets and the study of novel compounds in rare malignancies. He also is involved in education at the Stanford University School of Medicine, serving as a lecturer and mentor to medical students, residents, and oncology fellows. Dr. Bui is the founding Editor-in-Chief of the journal “Current Problems in Cancer: Case Reports”, an international, peer-reviewed journal that publishes groundbreaking cases that give insight into redefining concepts in cancer. He also serves as the Chair of the Data Safety Monitoring Committee at the Stanford Cancer Institute, overseeing the board that reviews all investigator-initiated cancer trials run at Stanford. -
Robert W. Carlson
Professor of Medicine (Oncology and General Internal Medicine/Medical Informatics) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsClinical investigations in breast cancer include institutional and NSABP studies of chemoprevention, adjuvant therapy, psychosocial interventions, treatment of metastatic disease, methods of decreasing anthracycline cardiotoxicity, and modulation of multidrug resistance. Research in meta-analysis includes the performance of meta-analysis in a wide variety of settings in cancer treatment by the international Meta-Analysis Group in Cancer.
-
Jennifer Caswell-Jin
Assistant Professor of Medicine (Oncology)
Current Research and Scholarly InterestsMy research is on the translational application of next-generation sequencing technologies to breast cancer care: (1) the value of hereditary cancer genetic panel testing in clinical practice, (2) the mechanisms by which inherited genetic variants lead to breast cancer development, and (3) the analysis of somatic tumor sequencing data to inform understanding of breast tumorigenesis, metastasis, and development of resistance in response to therapeutics.
